Full Text
HTA80 Impact of Restricted EU Market Access Decisions on Patient Access To Medicines in Multiple Myeloma

Abstract

Authors

C Alleman G. Katsikostas-Michopoulos B Fora A Azough A Griffin S Hickson D Rollmann J Mckendrick

Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×